[Our experience in the use of prostatilen in urology].

Abstract

Prostatilen was used in 1115 patients with chronic pyelonephritis and prostatitis. It is shown that prostatilen has a corrective effect on hemocoagulation and immunity disorders, restores microcirculation, suppresses inflammation in the kidney and prostate. Thus, prostatilen is a pathogenetically sound drug for treatment in urogenital inflammation while in chronic prostatitis it can be used as a basic therapy.

• Authors: S Kh Al'-Shukri, Iu A Bobkov, A G Gorbachev, I V Kuz'min, V N Tkachuk
• Journal: Urologiia (Moscow, Russia : 1999) (Urologiia) 2003 Nov-Dec Issue 6 Pg. 32-6 ISSN: 1728-2985 [Print] Russia (Federation)
• Vernacular Title: Nash opyt primeneniia prostatilena v urologii.
• PMID: 14708243 (Publication Type: Comparative Study, English Abstract, Journal Article)

Chemical References

• Adjuvants, Immunologic
• Anti-Inflammatory Agents
• Peptides
• prostatilen

Topics

• Adjuvants, Immunologic (therapeutic use)
• Adult
• Aged
• Anti-Inflammatory Agents (therapeutic use)
• Blood Coagulation (drug effects)
• Chronic Disease
• Humans
• Immunity, Cellular (drug effects)
• Kidney (blood supply, drug effects)
• Male
• Microcirculation (drug effects)
• Middle Aged
• Peptides (therapeutic use)
• Prostate (blood supply, drug effects)
• Prostatitis (complications, drug therapy, immunology, physiopathology)
• Pyelonephritis (complications, drug therapy, immunology, physiopathology)
• Urology